Overview
Latent Health has raised $80M in a Series A round on Mar 19, 2026, with participation from Spark Capital. The company scaling medication access with clinical AI. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the software development sector, Latent Health is positioned to capitalize on growing demand for innovative solutions in this space. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
With $80M now on the balance sheet, Latent Health enters a new phase of growth that typically involves rapid hiring, technology upgrades, and vendor evaluations. For sales professionals and service providers, this represents a prime opportunity to engage while budget allocation decisions are being made and the team is actively building out its operational infrastructure.
Why contact Latent Health now
With $80M in fresh capital from Series A, Latent Health is entering a rapid growth phase. Post-funding startups typically increase headcount by 30-50% and begin evaluating new tools and services immediately. The founders and decision-makers are actively taking meetings right now — making this the perfect time to connect before their calendars fill up.
Founders & Contacts
Investors
Company Facts
| Company | Latent Health |
| Amount Raised | $80M |
| Funding Round | Series A |
| Date Raised | Mar 19, 2026 |
| Founded | 2022 |
| Industry | Software Development |
| Founders |
Get Verified Founder Emails
Access verified email addresses and contact details for Latent Health's founders and thousands of other funded startups.
Start Free Trial